Pliant Therapeutics to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, will participate in the following conferences in March. Cowen 42nd Annual Health Care Conference: Dr. […]